β-Blockers are best antiarrhythmics for reducing post-MI mortality

Larsen JA, Kadish AH, Schwartz JB. Proper use of antiarrhythmic therapy for reduction of mortality after myocardial infarction. Drugs & Aging 2000 16(5); 341–350 Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984; 24: 129–47 Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781–8 Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227–33 Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801–7 Pedersen TR. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction. N Engl J Med 1985; 313: 1055–8 β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA 1982; 247: 1707–14 Hjalmarson A, Elmfeldt D, Herlitz J, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trial. Lancet 1981; 2: 823–7 International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl Med 1984; 310: 9–15 Thrombolysis in Myocardial Infarction (TIMI) Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial. N Engl J Med 1989; 320: 618–27 Julian DG, Prescott RJ, Jackson FS, et al. Controlled trial of sotalol for one year after myocardial infarction. Lancet 1982; 1: 1142–7 Mason JW, Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993; 329: 445–51 Mason JW. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachy arrhythmias. N Engl J Med 1993; 329: 452–8 Waldo AL, Camm AJ, DeRuyter H, the SWORD Investigators, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996; 348: 7–12 Sanderson J. The SWORD of Damocles [commentary]. Lancet 1996; 348: 2–3 Cairns JA, Connolly SJ, Roberts R, Canadian Myocardial Infarction Arrythmia Trial Investigators, et al. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 1997; 349: 675–82 Julian DG, Camm AJ, Frangin G, European Myocardial Infarct Amiodarone Trial Investigators, et al. Randomised trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 667–74 Held HP, Yusef S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ 1989; 299: 1187–92 Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988; 319: 385–92 Wong SC, Greenberg H, Hager WD, et al. Effects of diltiazem on recurrent myocardial infarction in patients with non-Q-wave myocardial infarctions. J Am Coll Cardiol 1992; 19(7): 1421–5 Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind randomized multicenter trial. N Engl J Med 1986; 315(7): 423–9 Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990; 66: 779–85 Hansen JF. Danish Study Group on Verapamil in Myocardial Infarction. Treatment with verapamil during and after an acute myocardial infarction: a review based on the danish verapamil infarction trials I and II. J Cardiovasc Pharmacol 1991; 18 Suppl. 6: S20–5 Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–40 Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–83